In CMS
May 1st, 2018
Doctors practicing genetics and genomics now have their own specialty code, D3, thanks to the Centers for Medicare & Medicaid Services (CMS). Physicians identify their Medicare physician specialty on the Medicare enrollment application or the Provider Enrollment, Chain, and Ownership System (PECOS). CMS uses the information for programmatic and claims processing. How this Code Helps Medical Adm...
In Coding
Mar 12th, 2010
Velaglucerase alfa for injection (VPRIV™) has been approved  by the U.S. Food and Drug Administration (FDA) for the treatment Gaucher disease—a rare genetic disorder that affects both children and adults. Gaucher disease occurs in people who do not produce enough of an enzyme called glucocerebrosidase. Without this enzyme, harmful amounts of a certain fatty substance ...
In Coding
Apr 13th, 2009
New clinical guidelines jointly released by American College of Obstetricians and Gynecologists (ACOG) and the Society of Gynecologic Oncologists (SGO) recommend all obstetrician/gynecologists (OB/GYNs) evaluate a patient’s risk for hereditary breast and ovarian cancer as a routine part of their practice. New Clinical Guidelines Released for OB-GYN Visits was last modified: July 5th, 2011 by ...
In CMS
Nov 1st, 2008
Someday, patient medical care will be differentiated based on individual biology. Physicians will prescribe medicine according to patient’s metabolism and other factors that cause certain prescription medication to work well with some, but not others. Someday may be sooner than you think. HHS Reports on Personalized Health Care was last modified: January 27th, 2016 by ...
Oct 1st, 2008
It’s Come a Long Way, Baby By Gail Donlin, CPC About nine in 1,000 babies in the United States are born with a congenital heart defect. This problem occurs as the baby’s heart is developing during pregnancy. A baby’s heart begins to develop at conception, and it’s completely formed by eight weeks. Congenital heart defects ...